TY - JOUR
T1 - A review of Vitamin D insufficiency and its management
T2 - A lack of evidence and consensus persists
AU - Gorey, S.
AU - Canavan, M.
AU - Robinson, S.
AU - O'Keeffe, S. T.
AU - Mulkerrin, E.
N1 - Publisher Copyright:
© The Author(s) 2018. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For permissions, please email: [email protected].
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Vitamin D deficiency is the most common nutritional deficiency worldwide, however uncertainty persists regarding the benefits of Vitamin D supplementation. Vitamin D is essential for calcium homeostasis, and has been linked to falls and fractures in older people. There are numerous risk factors for Vitamin D deficiency, chief among them old age. Studies of Vitamin D supplementation have given mixed signals, but over all there is evidence of benefit for those with risk factors for deficiency. International guidelines recommend Vitamin D target levels of >25 to >80 nmol/l, best achieved by a daily dose of 800-1000 IU. Large bolus doses should be avoided. There are still unanswered questions regarding Vitamin D supplementation and target levels. There is need for well designed and powered trials to achieve consensus.
AB - Vitamin D deficiency is the most common nutritional deficiency worldwide, however uncertainty persists regarding the benefits of Vitamin D supplementation. Vitamin D is essential for calcium homeostasis, and has been linked to falls and fractures in older people. There are numerous risk factors for Vitamin D deficiency, chief among them old age. Studies of Vitamin D supplementation have given mixed signals, but over all there is evidence of benefit for those with risk factors for deficiency. International guidelines recommend Vitamin D target levels of >25 to >80 nmol/l, best achieved by a daily dose of 800-1000 IU. Large bolus doses should be avoided. There are still unanswered questions regarding Vitamin D supplementation and target levels. There is need for well designed and powered trials to achieve consensus.
UR - http://www.scopus.com/inward/record.url?scp=85057045864&partnerID=8YFLogxK
U2 - 10.1093/qjmed/hcy126
DO - 10.1093/qjmed/hcy126
M3 - Review article
SN - 1460-2725
VL - 112
SP - 165
EP - 167
JO - QJM: An International Journal of Medicine
JF - QJM: An International Journal of Medicine
IS - 3
ER -